First real-world study on the effectiveness and tolerability of rimegepant for acute migraine therapy in Chinese patients.

Acute treatment effectiveness Rimegepant showed a significant trend in decreasing the percentages of participants who experienced moderate to severe pain in all three groups ( p < 0.05) (Fig. 1 ).

also in 6,248 other papers